Erlanger Health Systems — Chattanooga, Tennessee

Erlanger Health Systems is a clinical research site located in Chattanooga, Tennessee, United States 37403.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Erlanger Health Systems has participated in 6 clinical trials.

Therapeutic areas: Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer.

Sponsors: Hoffmann-La Roche, NCIC Clinical Trials Group, Sanofi.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Erlanger Health Systems?

Erlanger Health Systems has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Erlanger Health Systems conducted?

Erlanger Health Systems has 6 clinical trials on record. Their work covers Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer.

Is Erlanger Health Systems accredited by Crixeo Health?

Erlanger Health Systems has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Erlanger Health Systems?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.